These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 8108188)

  • 21. The cardiovascular and renal effects of acute and chronic inhibition of nitric oxide production in fetal sheep.
    Yu ZY; Lumbers ER; Simonetta G
    Exp Physiol; 2002 May; 87(3):343-51. PubMed ID: 12089602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of endothelium-derived relaxing factor inhibition on the umbilical-placental circulation in fetal lambs in utero.
    Chang JK; Roman C; Heymann MA
    Am J Obstet Gynecol; 1992 Feb; 166(2):727-34. PubMed ID: 1536259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of interactions between nitric oxide and angiotensin II on pressure diuresis and natriuresis.
    Madrid MI; García-Salom M; Tornel J; De Gasparo M; Fenoy FJ
    Am J Physiol; 1997 Nov; 273(5):R1676-82. PubMed ID: 9374809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelium-derived relaxing factor influences renal vascular resistance.
    Radermacher J; Förstermann U; Frölich JC
    Am J Physiol; 1990 Jul; 259(1 Pt 2):F9-17. PubMed ID: 2115741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal dysfunction after chronic blockade of nitric oxide synthesis.
    Cachofeiro V; Fortepiani LA; Navarro-Cid J; Lahera V; García-Estañ J
    Antioxid Redox Signal; 2002 Dec; 4(6):885-91. PubMed ID: 12573137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal effects of acute amino acid infusion in hypertension induced by chronic nitric oxide blockade.
    Qiu C; Engels K; Samsell L; Baylis C
    Hypertension; 1995 Jan; 25(1):61-6. PubMed ID: 7843755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide synthesis inhibition does not impair water immersion-induced renal vasodilation in humans.
    Dijkhorst-Oei LT; Boer P; Rabelink TJ; Koomans HA
    J Am Soc Nephrol; 2000 Jul; 11(7):1293-1302. PubMed ID: 10864586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of renal perfusion pressure on renal interstitial hydrostatic pressure and Na+ excretion: role of endothelium-derived nitric oxide.
    Nakamura T; Alberola AM; Salazar FJ; Saito Y; Kurashina T; Granger JP; Nagai R
    Nephron; 1998; 78(1):104-11. PubMed ID: 9453411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure.
    Lahera V; Salom MG; Miranda-Guardiola F; Moncada S; Romero JC
    Am J Physiol; 1991 Dec; 261(6 Pt 2):F1033-7. PubMed ID: 1750517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myogenic vascular regulation in skeletal muscle in vivo is not dependent of endothelium-derived nitric oxide.
    Ekelund U; Björnberg J; Grände PO; Albert U; Mellander S
    Acta Physiol Scand; 1992 Feb; 144(2):199-207. PubMed ID: 1575052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of endothelium-derived nitric oxide in control of renal microvasculature in aging male rats.
    Reckelhoff JF; Manning RD
    Am J Physiol; 1993 Nov; 265(5 Pt 2):R1126-31. PubMed ID: 8238614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide.
    Salazar FJ; Pinilla JM; López F; Romero JC; Quesada T
    Hypertension; 1992 Jul; 20(1):113-7. PubMed ID: 1618546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of NG-monomethyl-L-arginine and L-arginine on acetylcholine renal response.
    Lahera V; Salom MG; Fiksen-Olsen MJ; Raij L; Romero JC
    Hypertension; 1990 Jun; 15(6 Pt 1):659-63. PubMed ID: 2347626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial natriuretic peptide.
    Hinder F; Booke M; Traber LD; Matsumoto N; Nishida K; Rogers S; Traber DL
    Crit Care Med; 1996 Jan; 24(1):131-6. PubMed ID: 8565518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms involved in the cardiovascular-renal actions of nitric oxide inhibition.
    Manning RD; Hu L; Williamson TD
    Hypertension; 1994 Jun; 23(6 Pt 2):951-6. PubMed ID: 8206634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoid-induced renal vasodilatation is mediated by a direct renal action involving nitric oxide.
    De Matteo R; May CN
    Am J Physiol; 1997 Dec; 273(6):R1972-9. PubMed ID: 9435651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of endothelium-derived relaxing factor on renal microvessels and pressure-dependent vasodilation.
    Hoffend J; Cavarape A; Endlich K; Steinhausen M
    Am J Physiol; 1993 Aug; 265(2 Pt 2):F285-92. PubMed ID: 8368337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide inhibition does not prevent the hypotensive response to increased renal perfusion in rabbits.
    Thomas CJ; Anderson WP; Woods RL
    Clin Exp Pharmacol Physiol; 1995 May; 22(5):345-51. PubMed ID: 7554426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of glomerular arteriolar tone by nitric oxide synthase inhibitors.
    Edwards RM; Trizna W
    J Am Soc Nephrol; 1993 Nov; 4(5):1127-32. PubMed ID: 7508276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal responses to intra-arterial administration of nitric oxide donor in dogs.
    Majid DS; Williams A; Kadowitz PJ; Navar LG
    Hypertension; 1993 Oct; 22(4):535-41. PubMed ID: 8406658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.